Table 3.
Per-lesion APCs by diabetes status and angiographic obstructive versus nonobstructive angiographic stenosis
| Without diabetes | With diabetes | |||||
|---|---|---|---|---|---|---|
| Nonobstructive | Obstructive | Nonobstructive | Obstructive | |||
| Variable | (n = 138) | (n = 107) | P value | (n = 49) | (n = 68) | P value |
| PV (mm3) | 44.2 (12.7, 107.2) | 55.9 (21.8, 145.3) | 0.0499 | 37.4 (9.1, 111.9) | 51.8 (14.8, 166.2) | 0.2299 |
| LD-NCP (mm3) | 0.40 (0, 1.40) | 0.60 (0.10, 2.50) | 0.1416 | 0.20 (0, 1.60) | 0.20 (0, 1.10) | 0.1119 |
| NCP (mm3) | 27.1 (8.6, 66.5) | 30.3 (12.4, 90.0) | 0.0506 | 15.1 (6.8, 58.8) | 25.1 (7.3, 77.2) | 0.0751 |
| CP (mm3) | 8.9 (0.70, 39.3) | 10.2 (1.5, 39.9) | 0.8131 | 12.4 (0.9, 53.3) | 12.5 (3.4, 70.6) | 0.3763 |
| %PAV | 42.6 (16.6) | 52.5 (16.8) | <0.0001 | 45.4 (18.2) | 52.7 (18.8) | 0.0532 |
| %PAV LD-NCP | 0.37 (0, 1.02) | 0.64 (0.04, 2.20) | 0.09222 | 0.15 (0, 0.66) | 0.27 (0, 1.02) | 0.1114 |
| %PAV NCP | 25.7 (16.6, 35.1) | 32.6 (19.2, 48.0) | 0.0290 | 22.8 (11.9, 31.4) | 26.4 (14.0, 37.9) | 0.2134 |
| %PAV CP | 10.9 (1.3, 25.9) | 10.2 (2.6, 25.7) | 0.9587 | 12.4 (1.2, 32.8) | 18.8 (6.1, 37.5) | 0.2399 |
| Remodeling index | 1.09 (0.19) | 1.06 (0.28) | 0.3184 | 1.09 (0.24) | 1.09 (0.30) | 0.9593 |
| PR, n (%) | 46 (33.3) | 31 (29.0) | 0.0637 | 15 (30.6) | 25 (36.8) | 0.6300 |
| HRP, n (%) | 58 (42.0) | 41 (38.3) | 0.5812 | 18 (36.7) | 23 (33.8) | 0.6882 |
| Lesion length (mm) | 12.0 (7.5, 23.0) | 12.8 (7.5, 26.0) | 0.2232 | 11.3 (5.8, 22.3) | 13.4 (7.0, 26.4) | 0.1098 |
| Stenosis (%) | 32.5 (16.5) | 53.7 (21.9) | <0.0001 | 33.7 (15.8) | 51.3 (20.4) | <0.0001 |
| CAD-RADS* | 1.8 (0.7) | 2.8 (1.0) | <0.0001 | 1.8 (0.6) | 2.7 (1.0) | <0.0001 |
Data are presented as median (quartile 1, quartile 3) or mean (SD), unless indicated otherwise as n (%).
*
CAD-RADS stenosis defined as 0 = 0%; 1 = 1–25%; 2 = 26–49%; 3 = 50–69%; 4 = 70–99%; 5 = 100%.